# Hope Medicine

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/hope-medicine
Canonical HTML page: https://gethealthbrief.com/entity/hope-medicine

## Recent coverage (1 stories)

### Hope Medicine Doses First Phase III Patient in Landmark Endometriosis Trial
2026-03-25 02:00:37 · Sentiment: Positive · Impact: 7/10 · Sources: 3

Hope Medicine has officially initiated its global Phase III clinical trial for HMI-115, a first-in-class monoclonal antibody targeting the prolactin receptor for endometriosis. The dosing of the first patient marks a critical transition toward non-hormonal therapeutic options for a condition affecting nearly 10% of women globally.
Full story: https://gethealthbrief.com/story/hope-medicine-phase-iii-endometriosis-trial-commences

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.